Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs Zymeworks Inc. (ZYME)

Fortrea Holdings Inc. and Zymeworks Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Zymeworks Inc. are of similar size ($2.0B and $2.0B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −3.38% against −69.8%. Fortrea Holdings Inc. has the higher net margin (−2.58% vs −404.0%) and the higher return on invested capital (0.59% vs 0.00%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 13 and Zymeworks Inc. on 5.

Valuation

Metric FTRE ZYME Biotechnology median
P/E n/m n/m 10.60
P/S 0.79 58.04 9.40
P/B 3.94 26.81 2.13
Price to free cash flow 12.27 n/m 25.18
EV/EBITDA 32.06 n/m 0.66
EV/Sales 1.10 50.75 9.02
Earnings yield (3.34%) (6.84%) (32.88%)
Free cash flow yield 8.15% (5.63%) (23.13%)

Profitability

Metric FTRE ZYME Biotechnology median
Gross margin 20.00% (246.66%) 68.51%
Operating margin 0.48% (418.99%) 0.00%
Net margin (2.58%) (404.00%) 0.00%
Free cash flow margin 6.41% (324.68%) 0.00%
Return on equity (12.34%) (72.31%) (51.96%)
Return on assets (2.51%) (37.25%) (46.06%)
Return on invested capital 0.59% 0.00% 0.00%

Growth

Metric FTRE ZYME Biotechnology median
Revenue growth (TTM) (3.38%) (69.78%) 6.76%
EPS growth (last fiscal year) (194.55%) 33.33% 29.88%
Revenue growth, 5-year CAGR 1.09% 22.16% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE ZYME Biotechnology median
Debt to equity 1.98 0.00 0.00
Current ratio 0.97 6.32 4.97
Net debt to EBITDA 266.13 2.81 1.01

Dividend

Metric FTRE ZYME Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FTRE ZYME Biotechnology median
Market cap 1.97b 2.04b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack